Controlling CRISPR-Cas9 Gene Editing.

Abstract

Cracking Down on CRISPR-Cas9 Off-target DNA editing by the CRISPR-Cas9 ribonucleoprotein nuclease in the experimental treatment of genetic disease is a safety concern. A recent study provides proof...